Relay Therapeutics Announces Full Dose Escalation Data for
Data from FGFRi-naïve FGFR2-fusion CCA patients represent subset of September 2022 presentation and remain consistent with previously reported results...
Source: globenewswire.com
Refocus Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Refocus Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.